Visanne (dienogest) / Bayer, Mochida  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Visanne (dienogest) / Mochida, Bayer
NCT00225199: Efficacy and Safety of SH T00660AA in Treatment of Endometriosis

Completed
3
198
Europe, RoW
Visanne (BAY86-5258, SH T00660AA), Placebo
Bayer
Endometriosis
 
09/06
NCT00225186: Safety and Efficacy of SH T00660AA in Treatment of Endometriosis

Completed
3
168
Europe, RoW
Visanne (SH T00660AA , BAY86-5258)
Bayer
Endometriosis
03/08
03/08
NCT01697111: Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis

Completed
3
312
Japan
EE20/DRSP(BAY86-5300), Placebo, Dienogest
Bayer
Endometriosis
03/14
12/14
NCT01822080: Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients

Checkmark
May 2016 - May 2016: 
Completed
3
250
RoW
Dienogest (Visanne, BAY86-5258), Placebo
Bayer
Endometriosis
04/15
11/15

Download Options